Richard Furie people liking feelings affection Richard Furie

Clinical Trial Shows Promise in Treating Lupus Nephritis With Existing Drug Belimumab

Despite existing treatments and advancements in medicine, 10–30% of people with lupus nephritis reach end-phase kidney failure.

As this condition can be fatal, patients with lupus nephritis are in need of more treatment options. The positive results of a phase 3 clinical trial led by Richard Furie, MD, chief of rheumatology at Northwell Health, indicate that the drug belimumab (brand name Benlysta) helps manage lupus nephritis.

The website is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.